Paroxetine Is a Direct Inhibitor of G Protein-Coupled Receptor Kinase 2 and Increases Myocardial Contractility

G protein-coupled receptor kinase 2 (GRK2) is a well-established therapeutic target for the treatment of heart failure. Herein we identify the selective serotonin reuptake inhibitor (SSRI) paroxetine as a selective inhibitor of GRK2 activity both in vitro and in living cells. In the crystal structur...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Thal, David M., Homan, Kristoff T., Chen, Jun, Wu, Emily K., Hinkle, Patricia M., Huang, Z. Maggie, Chuprun, J. Kurt, Song, Jianliang, Gao, Erhe, Cheung, Joseph Y., Sklar, Larry A., Koch, Walter J., Tesmer, John J.G.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3500392/
https://ncbi.nlm.nih.gov/pubmed/22882301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cb3003013
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak